Case Fetal Rate and Factors Associated with Deaths due to COVID-19 in Damnoen Saduak Hospital, Ratchaburi Province

Authors

  • Phisan Chumchuen Damnoen Saduak, Ratchaburi Hospital
  • Sitthichai Banchongcharoenlert Damnoen Saduak, Ratchaburi Hospital

Keywords:

Covid-19, Risk factor, Death

Abstract

       A Retrospective analytic study aimed to study the mortality rate and the factor associated with the death of COVID-19 patients. The population is all inpatients diagnosed with COVID-19 from January to November 2021.

       A total of 4,909 people were collected. The research instrument was an individualized data collection to collect general data, laboratory data, and treatment outcomes with an index of congruence of 0.91. The data were analyzed using descriptive statistics and inferential statistics. Univariate analysis and multiple logistic regression were used for identifying risk factors and presenting adjusted odds ratio (ORadj), 95% CI, significance level at p-value<0.05. The study results showed that

          1. The case fatality rate of COVID-19 patients is 1.61%.

          2. Factors related to the death of COVID-19 patients statistically significant (p<.001) were: Older than 50 (ORadj=7.61; 95%CI=3.89-14.89), hypertension (ORadj=3.37; 95%CI=2.12-5.36), diabetes (ORadj=3.69; 95%CI=2.32-5.88), Heart disease (ORadj=4.94; 95%CI=2.45-9.95), stage 4-5 chronic kidney disease (ORadj=8.54; 95%CI=3.79-19.23), serum sodium levels less than 130 mmol/l (ORadj=5.84; 95%CI=3.08-11.07), serum bicarbonate less than 20 mmol/l (ORadj=11.24; 95%CI=6.97-18.13), GFR less than 60 ml/min/1.73m2 (ORadj=12.04; 95%CI=7.46-19.44) and stroke (ORadj=3.47; 95%CI=1.65-7.32; p-value=0.001) but no found a relationship between the sexes, chronic lung disease, cancer and cirrhosis with death of COVID-19 patients.

        Therefore, if various factors are found in patients with COVID-19, they should prompt treatment and surveillance to reduce deaths.

References

Alfano, G., Fontana, F., Mori, G., Giaroni, F., Ferrari, A., Giovanella, S., … Pinti, M. (2021). Acid base disorders in patients with COVID-19. International Urology and Nephrology. https://doi.org/10.1007/s11255-021-02855-1

Alqahtani, J. S., Oyelade, T., Aldhahir, A. M., Alghamdi, S. M., Almehmadi, M., Alqahtani, A. S., … Hurst, J. R. (2020, May 1). Prevalence, severity and mortality associated with COPD and smoking in patients with COVID-19: A rapid systematic review and meta-analysis. PLoS ONE, Vol. 15. Public Library of Science. https://doi.org/10.1371/journal.pone.0233147

Bhaskaran, K., Bacon, S., Evans, S. J., Bates, C. J., Rentsch, C. T., MacKenna, B., … Goldacre, B. (2021). Factors associated with deaths due to COVID-19 versus other causes: population-based cohort analysis of UK primary care data and linked national death registrations within the OpenSAFELY platform. The Lancet Regional Health - Europe, 6, 100109. https://doi.org/10.1016/j.lanepe.2021.100109

Chhetri, S., Khamis, F., Pandak, N., Al Khalili, H., Said, E., & Petersen, E. (2020). A fatal case of COVID-19 due to metabolic acidosis following dysregulate inflammatory response (cytokine storm). IDCases, 21. https://doi.org/10.1016/j.idcr.2020.e00829

Chow, N., Fleming-Dutra, K., Gierke, R., Hall, A., Hughes, M., Pilishvili, T., … Ussery, E. (2020). Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 — United States, February 12–March 28, 2020. MMWR. Morbidity and Mortality Weekly Report, 69(13), 382–386. https://doi.org/10.15585/mmwr.mm6913e2

Clift, A. K., Coupland, C. A. C., Keogh, R. H., Diaz-Ordaz, K., Williamson, E., Harrison, E. M., … Hippisley-Cox, J. (2020). Living risk prediction algorithm (QCOVID) for risk of hospital admission and mortality from coronavirus 19 in adults: national derivation and validation cohort study. The BMJ, 371. https://doi.org/10.1136/bmj.m3731

Deng, G., Yin, M., Chen, X., & Zeng, F. (2020, April 28). Clinical determinants for fatality of 44,672 patients with COVID-19. Critical Care, Vol. 24, p. 179. BioMed Central Ltd. https://doi.org/10.1186/s13054-020-02902-w

Department of Medical Services: Ministry of Public Health Thailand. (2021). CPG COVID-19. Retrieved January 2, 2022, from https://covid19.dms.go.th/Content/Select_Landding_page?contentId=155

Epidemiology Working Group for NCIP Epidemic Response: Chinese Center for Disease Control and Prevention. (2020). [The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China]. Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi, 41(2), 145–151. https://doi.org/10.3760/cma.j.issn.0254-6450.2020.02.003

Lodyagin, A. N., Batotsyrenov, B. V., Shikalova, I. A., & Voznyuk, I. A. (2020). Acidosis and toxic hemolysis – goals of pathogenetictreatment of polyorgan pathology in COVID-19. Bulletin of Restorative Medicine, 97(3), 25–30. https://doi.org/10.38025/2078-1962-2020-97-3-25-30

McGoogan JM. (2020). Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China. JAMA, 323(13), 1239–1242.

Sawanpanyalert, N., Sirijatuphat, R., Sangsayunh, P., Putcharoen, O., Manosuthi, W., Intalapaporn, P., … Chokephaibulkit, K. (2021). ASSESSEMENT OF OUTCOMES FOLLOWING IMPLEMENTATION OF ANTIVIRAL TREATMENT GUIDELINES FOR COVID-19 DURING THE FIRST WAVE IN THAILAND. The Southeast Asian Journal of Tropical Medicine and Public Health, 52(4). Retrieved from https://journal.seameotropmednetwork.org/index.php/jtropmed/article/view/490

Shevel, E. (2021). Conditions Favoring Increased COVID-19 Morbidity and Mortality: Their Common Denominator and its Early Treatment. Missouri Medicine, 118(2), 113–115. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/33840847

Stokes, E. K., Zambrano, L. D., Anderson, K. N., Marder, E. P., Raz, K. M., El Burai Felix, S., … Fullerton, K. E. (2020). Coronavirus Disease 2019 Case Surveillance — United States, January 22–May 30, 2020. MMWR. Morbidity and Mortality Weekly Report, 69(24), 759–765. https://doi.org/10.15585/mmwr.mm6924e2

Tzoulis, P., Waung, J. A., Bagkeris, E., Hussein, Z., Biddanda, A., Cousins, J., … Baldeweg, S. E. (2021). Dysnatremia is a Predictor for Morbidity and Mortality in Hospitalized Patients with COVID-19. Journal of Clinical Endocrinology and Metabolism, 106(6), 1637–1648. https://doi.org/10.1210/clinem/dgab107

Williamson, E. J., Walker, A. J., Bhaskaran, K., Bacon, S., Bates, C., Morton, C. E., … Goldacre, B. (2020). Factors associated with COVID-19-related death using OpenSAFELY. Nature, 584(7821), 430–436. https://doi.org/10.1038/s41586-020-2521-4

Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., … Cao, B. (2020). Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet, 395(10229), 1054–1062. https://doi.org/10.1016/S0140-6736(20)30566-3

Downloads

Published

2022-04-27

Issue

Section

Research Articles